High-dose, conventionally fractionated thoracic reirradiation for lung tumors.

BACKGROUND Loco-regional recurrences and second primary lung tumors are not uncommon after high-dose thoracic radiotherapy. The availability of improved radiotherapy techniques increases options for reirradiation. We describe a single-institutional experience with high-dose conventional thoracic reirradiation for both loco-regional recurrences and new primary tumors. METHODS Retrospective chart review of patients undergoing reirradiation between February 2004 and February 2013. RESULTS Of 24 patients identified, 54% had a loco-regional recurrence, and 46% a new primary tumor. The majority (63%) had stage III NSCLC at both initial and second treatment; median interval between treatments was 51 months (5-189), median follow-up after reirradiation was 19.3 months (95% CI: 2.8-35.9). Median overall survival (OS) after reirradiation was 13.5 months, with 1-year survival 51%. Median event-free survival (EFS) was 8.4 months. Median time between reirradiation and local progression (n=8) or distant progression (n=8) was 6.7 and 11.8 months, respectively. Three patients died with possible grade 5 bleeding. Other toxicities were uncommon. Planning target volume (PTV) at reirradiation was the most important prognostic factor; PTV <300 versus ≥300cc was significantly associated with median OS (17.4 vs 8.2 months, p=0.03) and EFS (14.1 vs 5.5 months, p=0.03). Magnitude of overlap between the initial and subsequent PTVs, and between dose distributions, did not influence survival. CONCLUSION Thoracic reirradiation with high dose conventional radiotherapy appears to deliver a meaningful survival benefit in low volume new primary or recurrent lung cancer. Further studies are needed to confirm these findings, and to establish reliable normal tissue tolerance doses for reirradiation.

[1]  I. Lax,et al.  Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapy. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  T. Ebara,et al.  Palliative re-irradiation for in-field recurrence after definitive radiotherapy in patients with primary lung cancer. , 2007, Anticancer research.

[3]  Steven F Petit,et al.  Reirradiation and stereotactic radiotherapy for tumors in the lung: dose summation and toxicity. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  Suresh Senan,et al.  Comparing rigid and deformable dose registration for high dose thoracic re-irradiation. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  J. V. van Meerbeeck,et al.  Hypofractionated external beam radiotherapy as retreatment for symptomatic non-small-cell lung carcinoma: an effective treatment? , 2004, International journal of radiation oncology, biology, physics.

[6]  C. la Vecchia,et al.  European cancer mortality predictions for the year 2014. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  F Levi,et al.  European cancer mortality predictions for the year 2012. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  A. Manatunga,et al.  The Reirradiation of Recurrent Bronchogenic Carcinoma with External Beam Irradiation , 1993, American journal of clinical oncology.

[9]  F Levi,et al.  European cancer mortality predictions for the year 2014. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  G. Jiang,et al.  Three-dimensional conformal radiotherapy for locoregionally recurrent lung carcinoma after external beam irradiation: a prospective phase I-II clinical trial. , 2003, International journal of radiation oncology, biology, physics.

[11]  Jose Belderbos,et al.  Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  W. Curran,et al.  Combination of longitudinal and circumferential three-dimensional esophageal dose distribution predicts acute esophagitis in hypofractionated reirradiation of patients with non-small-cell lung cancer treated in stereotactic body frame. , 2005, International journal of radiation oncology, biology, physics.

[13]  M. Kinay,et al.  Is re-irradiation effective in symptomatic local recurrence of non small cell lung cancer patients? A single institution experience and review of the literature. , 2009, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[14]  C. Sima,et al.  Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance. , 2013, The Journal of thoracic and cardiovascular surgery.

[15]  R. Melbye,et al.  Lung cancer: Retreatment of local recurrence after definitive irradiation , 1982, Cancer.

[16]  M. Mehta,et al.  Reirradiation for Locoregionally Recurrent Lung Cancer: Outcomes in Small Cell and Non–Small Cell Lung Carcinoma , 2014, American journal of clinical oncology.

[17]  Joe Y. Chang,et al.  Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation. , 2010, International journal of radiation oncology, biology, physics.

[18]  E. Wouters,et al.  Massive haemoptysis after radiotherapy in inoperable non-small cell lung carcinoma: is endobronchial brachytherapy really a risk factor? , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  B. Johnson,et al.  Second lung cancers in patients after treatment for an initial lung cancer. , 1998, Journal of the National Cancer Institute.

[20]  Kenneth E Rosenzweig,et al.  Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT) , 2013, Radiation Oncology.

[21]  T. Nakajima,et al.  Reirradiation for locally recurrent lung cancer previously treated with radiation therapy. , 2002, International journal of radiation oncology, biology, physics.

[22]  T. Tada,et al.  Non-small-cell lung cancer: reirradiation for loco-regional relapse previously treated with radiation therapy , 2005, International Journal of Clinical Oncology.

[23]  D. Hayes,et al.  Late Complications of High-Dose (≥66 Gy) Thoracic Conformal Radiation Therapy in Combined Modality Trials in Unresectable Stage III Non-small Cell Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[24]  D. Ball,et al.  Palliative retreatment of locally-recurrent lung cancer after radical radiotherapy. , 1987, The Medical journal of Australia.

[25]  B. Loo,et al.  Stereotactic Ablative Radiotherapy for Reirradiation of Locally Recurrent Lung Tumors , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[26]  Suresh Senan,et al.  Radiotherapy for lung cancer: clinical impact of recent technical advances. , 2009, Lung cancer.

[27]  S. Senan,et al.  Clinical application of a novel hybrid intensity-modulated radiotherapy technique for stage III lung cancer and dosimetric comparison with four other techniques. , 2012, International journal of radiation oncology, biology, physics.

[28]  W. Curran,et al.  Thoracic reirradiation for symptomatic relief after prior radiotherapeutic management for lung cancer. , 2000, American journal of clinical oncology.

[29]  Joe Y. Chang,et al.  Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancer. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  E. Smit,et al.  Changes in non-surgical management of stage III non-small cell lung cancer at a single institution between 2003 and 2010 , 2014, Acta oncologica.

[31]  M. Martel,et al.  Aortic dose constraints when reirradiating thoracic tumors. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[32]  N. Lee,et al.  Practical considerations in the re-irradiation of recurrent and second primary head-and-neck cancer: who, why, how, and how much? , 2011, International journal of radiation oncology, biology, physics.

[33]  B. Jeremic,et al.  Chest reirradiation with external beam radiotherapy for locally recurrent non-small-cell lung cancer: a review. , 2011, International journal of radiation oncology, biology, physics.